Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TASER-Pediatrics: Prospective Monitoring of Second-line Antiretroviral Therapy Failure and Resistance in Children

NCT01788891 is registered in ClinicalTrials.gov with The HIV Netherlands Australia Thailand Research Collaboration as lead sponsor.

NCT NCT01788891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01788891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TASER-Pediatrics: Prospective Monitoring of Second-line Antiretroviral Therapy Failure and Resistance in Children
Lead sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Phase
Observational
Overall status
Completed
Start date
January 31, 2011
Completion date
July 31, 2015
Enrollment
300 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

treatment failure of second-line art in asian hiv-infected children